(27 days)
K213972 – Mac-Lab, CardioLab, ComboLab & MLCL Client Software AltiX
No
The document describes a system for recording, displaying, and transmitting hemodynamic and electrophysiology data. It mentions standard data processing functions like filtering, digitizing, amplifying, measuring, and calculating. There is no mention of AI, ML, deep learning, or any related terms in the intended use, device description, or performance studies sections. The predicate device also does not indicate AI/ML capabilities.
No.
The device is used to record, display, and transmit data for diagnostic purposes, not to provide therapy.
Yes
The devices (Mac-Lab, CardioLab, ComboLab, MLCL Client Software) are indicated for recording, displaying, and/or transmitting hemodynamic and electrophysiology data and measurements for storage, analysis, and viewing, which are functions consistent with diagnostic devices used to assess a patient's condition. While they are explicitly stated not to be patient monitors or intended to alert practitioners of changes in patient status, the act of collecting and preparing data for analysis and diagnosis falls within the scope of a diagnostic device.
No
The device description explicitly states that Mac-Lab, CardioLab, and ComboLab are "hemodynamic and electrophysiology (EP) recording systems" and are used to "process, display and record hemodynamic and electrophysiology (EP) data". It also mentions data acquisition via "procedural information devices, imaging devices and interfaced data devices". While the MLCL Client Software is described as core application software that can be installed on a stand-alone workstation, the overall system includes hardware components for data acquisition and processing, as evidenced by the description of the Mac-Lab, CardioLab, and ComboLab systems. The non-clinical tests also reference standards related to medical electrical equipment (IEC 60601 series), further indicating the presence of hardware.
Based on the provided information, the devices (Mac-Lab, CardioLab, ComboLab, and MLCL Client Software) are not IVDs (In Vitro Diagnostics).
Here's why:
- Intended Use: The intended use clearly states that these systems are used to record, display, and transmit hemodynamic and electrophysiology data and measurements from patients during procedures. This data is acquired directly from the patient's body (in vivo), not from samples taken from the body (in vitro).
- Device Description: The description reinforces that the devices process, display, and record physiological data acquired real-time from the patient.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, urine, tissue, etc.) or providing diagnostic information based on such analysis. The focus is on physiological measurements and data management.
IVDs are specifically designed to examine specimens derived from the human body to provide information for the diagnosis, monitoring, or treatment of a disease or condition. These devices do not fit that description.
N/A
Intended Use / Indications for Use
Mac-Lab: The Mac-Lab system is indicated for use on patients of all ages when a physician determines that a patient would benefit from a hemodynamic procedure. Mac-Lab may be used in a variety of hospital and clinical settings to record hemodynamic data and measurements which may then be displayed and/or transmitted.
CardioLab: The CardioLab system is indicated for use on patients of all ages when a physician determines that a patient would benefit from an electrophysiology procedure. CardioLab may be used in a variety of hospital and clinical settings to record electrophysiology data and measurements which may then be displayed and/or transmitted.
ComboLab: The ComboLab system is indicated for use on patients of all ages when a physician determined that a patient would benefit from either a hemodynamic or electrophysiology procedure. Combol ab may be used in a variety of hospital and clinical settings to record hemodynamic and electrophysiology data and measurements which may then be displayed and/or transmitted.
MLCL Client Software: The MLCL Client Software is intended for recording, documenting and/or reviewing clinical data for hemodynamic and electrophysiology procedures and may then be displayed, filtered, digitized, amplified, measured, calculated and/or transmitted for storage, analysis and viewing at distributed locations.
Product codes (comma separated list FDA assigned to the subject device)
DQK
Device Description
Mac-Lab and CardioLab are hemodynamic and electrophysiology (EP) recording systems, respectively. A third configuration, ComboLab, allows the user to access both CardioLab and Mac-Lab functions, though only one application may be accessed at a time. These devices are used during interventional and related procedures to process, display and record hemodynamic and electrophysiology (EP) data depending on the type of procedure performed. The data is acquired and displayed real-time for multiple physiological parameters to allow the user to view the data. The data may be entered manually through the use of a dedicated keyboard/mouse/barcode scanner or acquired via procedural information devices, imaging devices and interfaced data devices, and may then be displayed, filtered, digitized, amplified, measured, and calculated. A fourth configuration, called the MLCL Client Software, is the core Mac-Lab and CardioLab application software which is available for installation on a stand-alone workstation (i.e. outside of the Mac-Lab/CardioLab/ComboLab acquisition systems described above). The MLCL Review Software may be used to record, document, analyze, store and transmit data, including data from supported patient monitors. Mac-Lab, CardioLab, ComboLab and the MLCL Client Software provide the ability to transmit patient data for storage, analysis and viewing at distributed locations within a clinical facility via network connectivity but may also be used stand-alone (not connected to a network). Mac-Lab, CardioLab, ComboLab and the MLCL Client Software are not intended to be used as a patient monitor and are not intended to alert the licensed health care practitioner of a change in patient status.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
all ages
Intended User / Care Setting
physician; variety of hospital and clinical settings
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Summary of Non-Clinical Tests: The subject devices and applications have been independently tested and conform to the following voluntary standards: IEC 60101-1 Ed 3.2 2020-08 CONSOLIDATED VERSON, IEC 60601-1-2 Ed 4.1 2020-09 CONSOLIDATED VERSION, IEC 60601-2-27 Ed 3.0 2011-03, IEC 60601-2-34 Ed 3.0 2011-05. In addition, the following standards were used to analyze the effectiveness of specific features and functionality of the subject devices even though the standards were not applicable in full: IEC 80601-2-30 Ed 2.0 2018-03, IEC 80601-2-55 Second Edition 2018-02, IEC 80601-2-56 Second Edition 2017-03, IEC 80601-2-61 Second Edition 2017-12 (Corrected version). The following quality assurance measures were applied to the development of the system: • Risk Analysis • Requirements Reviews • Technical Design Reviews • Formal Design Reviews • Testing on unit level (Module verification) • Integration testing (System verification) • Performance testing (Verification) • System Testing: - Safety testing (Verification) - System performance testing (Verification). The testing and results did not raise new or different questions of safety and effectiveness than those associated with the predicate device. Software documentation for a "Basic" level of concern was also considered as a point of comparison to the predicate device. The conclusions drawn from the nonclinical tests demonstrate that the proposed device is as safe, as effective and performs as well as the legally marketed predicate device.
Summary of Clinical Tests: The subject of this premarket submission, Mac-Lab, CardioLab, ComboLab and MLCL Client Software AltiX AI.i, did not require clinical studies to support substantial equivalence.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K213972 – Mac-Lab, CardioLab, ComboLab & MLCL Client Software AltiX
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
K202943 – OptoMonitor3 (Opsens, Inc., now part of Haemonetics), K173381 – Nexxis OR (Barco N.V.)
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.1425 Programmable diagnostic computer.
(a)
Identification. A programmable diagnostic computer is a device that can be programmed to compute various physiologic or blood flow parameters based on the output from one or more electrodes, transducers, or measuring devices; this device includes any associated commercially supplied programs.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: on the left, there is a symbol representing the Department of Health & Human Services-USA, and on the right, there is the text "FDA U.S. FOOD & DRUG ADMINISTRATION" in blue. The FDA logo is a symbol of the agency's mission to protect and promote public health through the regulation and supervision of food safety, tobacco, pharmaceuticals, medical devices, and other related products.
December 12, 2024
GE Medical Systems Information Technologies, Inc. James Turner Sr. Regulatory Affairs Manager 3114 N Grandview Blvd Waukesha, Wisconsin 53188
Re: K243540
Trade/Device Name: Mac-Lab (AltiX AI.i); CardioLab (AltiX AI.i); ComboLab (AltiX AI.i); MLCL Client Software (AltiX AI.i) Regulation Number: 21 CFR 870.1425 Regulation Name: Programmable Diagnostic Computer Regulatory Class: Class II Product Code: DQK Dated: November 15, 2024 Received: November 15, 2024
Dear James Turner:
We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).
Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30. Design controls; 21 CFR 820.90. Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.
All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-device-advicecomprehensive-regulatory-assistance/unique-device-identification-system-udi-system.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatory
2
assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Stephen C. Browning -S
LCDR Stephen Browning Assistant Director Division of Cardiac Electrophysiology, Diagnostics, and Monitoring Devices Office of Cardiovascular Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
3
Indications for Use
Submission Number (if known)
K243540
Device Name
Mac-Lab (AltiX AI.i); CardioLab (AltiX Al.i); ComboLab (AltiX Al.i); MLCL Client Software (AltiX Al.i)
Indications for Use (Describe)
Mac-Lab:
The Mac-Lab system is indicated for use on patients of all ages when a physician determines that a patient would benefit from a hemodynamic procedure. Mac-Lab may be used in a variety of hospital and clinical settings to record hemodynamic data and measurements which may then be displayed and/or transmitted.
CardioLab:
The CardioLab system is indicated for use on patients of all ages when a physician determines that a patient would benefit from an electrophysiology procedure. CardioLab may be used in a variety of hospital and clinical settings to record electrophysiology data and measurements which may then be displayed and/or transmitted.
ComboLab:
The ComboLab system is indicated for use on patients of all ages when a physician determined that a patient would benefit from either a hemodynamic or electrophysiology procedure. Combol ab may be used in a variety of hospital and clinical settings to record hemodynamic and electrophysiology data and measurements which may then be displayed and/or transmitted.
MLCL Client Software:
The MLCL Client Software is intended for recording, documenting and/or reviewing clinical data for hemodynamic and electrophysiology procedures and may then be displayed, filtered, digitized, amplified, measured, calculated and/or transmitted for storage, analysis and viewing at distributed locations.
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
er-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
4
Image /page/4/Picture/0 description: The image shows the GE HealthCare logo. The logo consists of a purple circular emblem with a stylized "GE" inside. To the right of the emblem is the text "GE HealthCare" in a matching purple color. The text is clean and modern, reflecting the company's focus on healthcare solutions.
510(k) Summary – K243540
In accordance with 21 CFR 807.92 the following summary of information is provided:
| Date: | 15 November 2024 |
|---|---|
| Submitter: | GE HealthCare |
| GE Medical Systems Information Technologies, Inc. | |
| 3114 N Grandview Blvd | |
| Waukesha, WI 53188 | |
| USA | |
| Primary Contact Person: | Mr. James T. Turner, MS |
| Sr. Regulatory Affairs Manager | |
| GE HealthCare | |
| (GE Medical Systems Information Technologies, Inc.) | |
| Telephone: 414 491 9895 | |
| Email: james.t.turner@gehealthcare.com | |
| Secondary Contact | |
| Person: | Ms. Michelle Huettner |
| Regulatory Affairs Director | |
| GE HealthCare | |
| Telephone: 901 558 8035 | |
| Email: michelle.huettner@gehealthcare.com | |
| Device Trade Name: | |
| (Brand) | Mac-Lab™ |
| CardioLab™ | |
| ComboLab | |
| MLCL Client Software | |
| Model/Version | AltiX Al.i |
| Common/Usual Name: | Hemodynamic and Electrophysiology (EP) Recording Systems |
| Classification Name: | |
| Product Code: | 21 CFR 870.1425 – Computer, Diagnostic Programmable |
| DQK | |
| Predicate Device: | K213972 – Mac-Lab, CardioLab, ComboLab & MLCL Client Software AltiX |
| Reference Devices: | K202943 – OptoMonitor3 (Opsens, Inc., now part of Haemonetics) |
| K173381 – Nexxis OR (Barco N.V.) | |
| Marketed Devices: | Mac-Lab, CardioLab, ComboLab and MLCL Client Software AltiX Al.i are |
| modifications of the cleared predicate devices (K213972). The primary | |
| changes are related to the introduction of a new version of the EP | |
| amplifier, updates to signal filtering and gain, inclusion of opSens/ | |
| HAEMONETICS Diastolic Pressure Ratio (dPR™), introduction of | |
| PruckaStream, and utilization of Barco Nexxis OR™ for video | |
| distribution. | |
| Device Description: | Mac-Lab and CardioLab are hemodynamic and electrophysiology (EP) |
| recording systems, respectively. A third configuration, ComboLab, | |
| allows the user to access both CardioLab and Mac-Lab functions, though | |
| only one application may be accessed at a time. | |
| These devices are used during interventional and related procedures to | |
| process, display and record hemodynamic and electrophysiology (EP) | |
| data depending on the type of procedure performed. The data is | |
| acquired and displayed real-time for multiple physiological parameters | |
| to allow the user to view the data. The data may be entered manually | |
| through the use of a dedicated keyboard/mouse/barcode scanner or | |
| acquired via procedural information devices, imaging devices and | |
| interfaced data devices, and may then be displayed, filtered, digitized, | |
| amplified, measured, and calculated. | |
| A fourth configuration, called the MLCL Client Software, is the core Mac- | |
| Lab and CardioLab application software which is available for | |
| installation on a stand-alone workstation (i.e. outside of the Mac- | |
| Lab/CardioLab/ComboLab acquisition systems described above). The | |
| MLCL Review Software may be used to record, document, analyze, store | |
| and transmit data, including data from supported patient monitors. | |
| Mac-Lab, CardioLab, ComboLab and the MLCL Client Software provide | |
| the ability to transmit patient data for storage, analysis and viewing at | |
| distributed locations within a clinical facility via network connectivity | |
| but may also be used stand-alone (not connected to a network). | |
| Mac-Lab, CardioLab, ComboLab and the MLCL Client Software are not | |
| intended to be used as a patient monitor and are not intended to alert | |
| the licensed health care practitioner of a change in patient status. | |
| Intended Use: | The intended use of the subject devices have not changed from that of |
| the cleared predicate devices. | |
| Mac-Lab | |
| The Mac-Lab system is indicated for use on patients of all ages when a | |
| physician determines that a patient would benefit from a hemodynamic | |
| procedure. Mac-Lab may be used in a variety of hospital and clinical | |
| settings to record hemodynamic data and measurements which may | |
| then be displayed and/or transmitted. | |
| CardioLab | |
| The CardioLab system is indicated for use on patients of all ages when a | |
| physician determines that a patient would benefit from an | |
| electrophysiology procedure. CardioLab may be used in a variety of | |
| hospital and clinical settings to record electrophysiology data and | |
| measurements which may then be displayed and/or transmitted. | |
| ComboLab | |
| The ComboLab system is indicated for use on patients of all ages when a | |
| physician determined that a patient would benefit from either a | |
| hemodynamic or electrophysiology procedure. ComboLab may be used | |
| in a variety of hospital and clinical settings to record hemodynamic and | |
| electrophysiology data and measurements which may then be displayed | |
| and/or transmitted. | |
| MLCL Client Software | |
| The MLCL Client Software is intended for recording, documenting | |
| and/or reviewing clinical data for hemodynamic and electrophysiology | |
| procedures and may then be displayed, filtered, digitized, amplified, | |
| measured, calculated and/or transmitted for storage, analysis and | |
| viewing at distributed locations. | |
| Indications for Use: | The indications for use of the subject devices have not changed from |
| that of the cleared predicate devices. | |
| Mac-Lab™ | |
| The Mac-Lab system is indicated for use on patients of all ages when a | |
| physician determines that a patient would benefit from a hemodynamic | |
| procedure. Mac-Lab may be used in a variety of hospital and clinical | |
| settings to record hemodynamic data and measurements, which may | |
| then be displayed, filtered, digitized, amplified, measured, and | |
| calculated and/or transmitted for storage, analysis and viewing at | |
| distributed locations. | |
| CardioLab™ | |
| The CardioLab system is indicated for use on patients of all ages when a | |
| physician determines that a patient would benefit from an | |
| electrophysiology procedure. CardioLab may be used in a variety of | |
| hospital and clinical settings to record electrophysiology data and | |
| measurements, which may then be displayed filtered, digitized, | |
| amplified, measured, and calculated and/or transmitted for storage, | |
| analysis and viewing at distributed locations. | |
| ComboLab | |
| The ComboLab system is indicated for use on patients of all ages when a | |
| physician determines that a patient would benefit from either a | |
| hemodynamic or electrophysiology procedure. ComboLab may be used |
5
Image /page/5/Picture/0 description: The image shows the GE HealthCare logo. The logo consists of a purple circular emblem with a stylized "GE" monogram inside. To the right of the emblem, the text "GE HealthCare" is written in a matching purple color. The text is in a clean, sans-serif font.
6
Image /page/6/Picture/0 description: The image shows the GE Healthcare logo. The logo consists of a purple circle with the letters "GE" inside, and the words "GE Healthcare" in purple next to the circle. The logo is simple and modern, and it is easily recognizable.
GE HealthCare
7
Image /page/7/Picture/0 description: The image contains the GE Health logo. The logo consists of a purple circular emblem with a stylized "GE" monogram inside. To the right of the emblem, the words "GE Health" are written in a simple, sans-serif font, also in purple. The overall design is clean and modern.
GE HealthCare
| | in a variety of hospital and clinical settings to record hemodynamic and
electrophysiology data and measurements, which may then be
displayed, filtered, digitized, amplified, measured, calculated and/or
transmitted for storage, analysis and viewing at distributed locations.
MLCL Client Software
The MLCL Client Software is indicated for use on patients of all ages
when a physician determines that a patient would benefit from either a
hemodynamic or electrophysiology procedure. MLCL Client Software
may be used in a variety of hospital and clinical settings to record,
document and/or review hemodynamic and electrophysiology data and
measurements, which may then be displayed, filtered, digitized,
amplified, measured, calculated and/or transmitted for storage, analysis
and viewing at distributed locations. | | |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Technology: | The Mac-Lab, CardioLab and ComboLab Recording Systems AltiX Al.i
employ the same fundamental scientific technology, basic design,
construction, materials, energy source, control mechanism, and
operating principles as the predicate devices, Mac-Lab, CardioLab,
Combolab and MLCL Client Software AltiX, in recording and displaying
hemodynamic and electrophysiology data.
The basic systems can acquire data from a variety of inputs which may
then be displayed, filtered, digitized, amplified, measured and
calculated. These systems also provide the ability to transmit patient
data for storage, analysis and viewing.
The table below summarizes the substantive feature/technological
differences between the predicate and proposed devices: | | |
| | Configuration | Predicate Device Features | Proposed Device Features |
| | Mac-Lab | • Diastolic Pressure Ratio
(dPR) not supported on
the device | • Diastolic Pressure Ratio
(dPR) incorporated in the
Mac-Lab software |
| | CardioLab | • Only a 128-channel option
is available for the Prucka
3 EP amplifier
• Does not support digital
waveform streaming to
external, only analog
output, binary or CSV data
extraction
• Included high and low
pass filters, powerline
filters and gain settings | • Provides an option to use
either a 128- or 64-channel
Prucka 3 EP amplifier
• PruckaStream makes
original digital signal data
available from the EP
amplifier and allows data
return
• Expanded customizations,
settings and capabilities to
help minimize noise and
provide better signal |
| | Mac-Lab &
CardioLab | • Utilizes video distribution
via HDMI splitters and
switches to replicate
displays | • Allows an alternate video
distribution system, Barco
Nexxis OR, to route video
signals and allows use of
single command inputs
(mouse, keyboard) for
connected devices |
| ComboLab utilizes the combined hardware and software features noted
in the table above for both CardioLab and Mac-Lab on a single platform.
The MLCL Client Software utilizes the combined software features from
the table above but does not include the hardware features (64-Channel
Prucka 3 EP amplifier).
The device's technological characteristics do not create new questions | | | |
| of safety or effectiveness, | | | |
| Data Supporting Safety
& Efficacy: | Summary of Non-Clinical Tests:
The subject devices and applications have been independently tested
and conform to the following voluntary standards:
• IEC 60101-1 Ed 3.2 2020-08 CONSOLIDATED VERSON
• IEC 60601-1-2 Ed 4.1 2020-09 CONSOLIDATED VERSION
• IEC 60601-2-27 Ed 3.0 2011-03
• IEC 60601-2-34 Ed 3.0 2011-05 | | |
| | In addition, the following standards were used to analyze the
effectiveness of specific features and functionality of the subject devices
even though the standards were not applicable in full:
• IEC 80601-2-30 Ed 2.0 2018-03
• IEC 80601-2-55 Second Edition 2018-02
• IEC 80601-2-56 Second Edition 2017-03
• IEC 80601-2-61 Second Edition 2017-12 (Corrected version) | | |
| | The following quality assurance measures were applied to the
development of the system:
• Risk Analysis
• Requirements Reviews
• Technical Design Reviews
• Formal Design Reviews
• Testing on unit level (Module verification)
• Integration testing (System verification)
• Performance testing (Verification)
• System Testing:
- Safety testing (Verification)
- System performance testing (Verification) | | |
8
Image /page/8/Picture/0 description: The image shows the logo for GE HealthCare. The logo consists of the GE monogram in a circle on the left, followed by the words "GE HealthCare" in a sans-serif font. The logo is purple in color.
9
Image /page/9/Picture/0 description: The image contains the GE Healthcare logo. The logo consists of a circular emblem on the left and the text "GE Healthcare" on the right. The emblem features a stylized "GE" monogram within a circular border. The text "GE Healthcare" is written in a sans-serif font and is purple.
GE HealthCare
| | The testing and results did not raise new or different questions of safety
and effectiveness than those associated with the predicate device.
Software documentation for a "Basic" level of concern was also
considered as a point of comparison to the predicate device. The
conclusions drawn from the nonclinical tests demonstrate that the
proposed device is as safe, as effective and performs as well as the
legally marketed predicate device. |
|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| | Summary of Clinical Tests: |
| | The subject of this premarket submission, Mac-Lab, CardioLab,
ComboLab and MLCL Client Software AltiX AI.i, did not require clinical
studies to support substantial equivalence. |
| Conclusion: | GE HealthCare considers Mac-Lab, CardioLab, ComboLab and MLCL
Client Software AltiX Al.i to be as safe, as effective, and performance is
comparable to the predicate device(s). |
| | The changes associated with the Mac-Lab, CardioLab, ComboLab and
MLCL Client Software AltiX Al.i do not create a new Intended Use and
represent similar technological characteristics, with no impact on the
control mechanisms, operating principle, and energy type. GE
HealthCare's quality system's design verification, and risk management
processes did not identify any new questions of safety or effectiveness,
hazards, unexpected results, or adverse effects stemming from the
changes to the predicate. |
| | Based on development under GE HealthCare's quality system, the
successful system and software verification and validation testing,
conformance to standards, and additional engineering bench testing
demonstrates that the subject device is comparable to, and hence as
safe and as effective for its Intended Use. |